EQUS® Oral tablets

Analgesic, Non-steroidal anti-inflammatory

Analgesic. Non-steroidal anti-inflammatory, indicated in the treatment of alterations in muscles, tendons, ligaments, joints and skin in horses.

Technical Specification

Species

Horses.

Dosage form

Oral tablet.

Therapeutic action

Analgesic, Non-steroidal anti-inflammatory

Composition

Each Tablet contains:                   
Phenylbutazone..............................1 g
Excipients q.s.p........................1 tablet

Indications

Analgesic. Non-steroidal anti-inflammatory, indicated in the treatment of alterations in muscles, tendons, ligaments, joints and skin in horses.

Route od administration and dosage

Oral route of administration.

Product dose:

2 tablets for each 500 k of weight, every 12 hours the first day of treatment, followed by one tablet for every 500 Kg of weight, every 12 hours for 5 to 7 days.  

Drug interactions

It is not recommended to use concomitantly with other pharmaceutical products.

Contraindications

  • Do not exceed a maximum dose of 4 g per horse per day.
  • Do not administer in animals hypersensitive to phenylbutazone.
  • Do not administer to animals with heart, kidney or liver failure, dehydrated animals, or in animals with hematological or bone marrow abnormalities.
  • Do not administer in pregnant or lactating females.

Special precautions for use

  • Do not exceed the established dose, since the therapeutic index of Phenylbutazone is low.
  • Avoid as much as possible its use in foals or older animals due to the risk of kidney toxicity.

Special precautions for the operator

Wash your hands after handling the product. In case of accidental ingestion, do not induce vomiting. Get medical help.

Warnings

Keep out of reach of children.

Adverse effects

Unwanted effects and adverse reactions:
Gastrointestinal adverse effects are the most important in phenylbutazone therapy in horses. Possible clinical signs include decreased appetite, depression, colic, weight loss, abdominal edema, hypoproteinemia (decreased blood protein), and diarrhea. In addition, bleeding and ulcers can occur in the mouth, esophagus, stomach, intestine, cecum, and right dorsal colon.

Guard period

Do not administer to animals intended for human consumption.

Observations

Special precautions for disposal of waste material:
Discard any unused product remains in its original container. Dispose of the waste of this product with care together with household waste. Do not dispose of empty containers or the rest of the product on the ground or water courses.

Conservation

Store in a cool and dry place, at room temperature between 15° and 30°C.

Condition of sale

To be supply only on veterinary prescription.

Presentation

10 tablets

Prepared by

Drag Pharma Laboratory.

Records

Chile: Reg. SAG Nº: 1464
Perú: Reg. SENASA F.99.21.I.0114

Countries where it is marketed

Imported and Distributed in Peru by:
Representaciones Durand SAC.
Av. Manuel Olguín N ° 501 Office N ° 604 Santiago de Surco Lima

You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).

Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian